12 hasil untuk "Chee Kay Cheung"
Menampilkan 1–12 · 0,55 detik · RSS
-
Artikel Jurnal
Novel Treatment Paradigms: Primary IgA Nephropathy
IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. Approximately 30% to 45% of patients progress to kidney failure (KF) within 20 to 25 years of diagnosis, and there has long been a lack of effective treatments. The therapeutic landscape in IgAN is rapidly evolving…
-
Artikel Jurnal
The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies
Immunoglobulin A nephropathy (IgAN), characterized by mesangial deposition of galactose-deficient-IgA1 (Gd-IgA1), is the most common biopsy-proven primary glomerulonephritis worldwide. Recently, an improved understanding of its underlying pathogenesis and the substantial risk of progression to…
-
Artikel Jurnal
Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management
IgA nephropathy (IgAN) is the commonest biopsy-reported primary glomerulonephritis worldwide. It has an incidence which peaks among young adults, and 30 to 40% of patients’ progress to end stage kidney disease within twenty years of diagnosis. Ten-year kidney survival rates have been reported to be…
-
Artikel Jurnal
Toscana virus meningo-encephalitis: an important differential diagnosis for elderly travellers returning from Mediterranean countries
Abstract Background Elderly patients have a long list of differentials for causes of acute confusion and altered consciousness levels, including infectious agents. In addition, elderly, retired patients often have more time to travel for tourism, particularly to exotic, warmer locations…
-
Artikel Jurnal
SARS-COV-2 vaccine responses in renal patient populations
Abstract Background Dialysis patients and immunosuppressed renal patients are at increased risk of COVID-19 and were excluded from vaccine trials. We conducted a prospective multicentre study to assess SARS-CoV-2 vaccine antibody responses in dialysis patients and renal transplant recipients, and…
-
Artikel Jurnal
Rituximab in Membranous Nephropathy
Membranous nephropathy (MN) is the most common cause of primary nephrotic syndrome among adults. The identification of phospholipase A2 receptor (PLA2R) as target antigen in most patients changed the management of MN dramatically, and provided a rationale for B-cell depleting agents such as…
-
Artikel Jurnal
Clinical scenarios of suboptimal response to rituximab in relapsing ANCA-associated vasculitis
BackgroundRituximab is effective for induction and maintenance of remission in relapsing ANCA-associated vasculitis (AAV), but some patients do not achieve complete remission or experience relapse despite treatment. We aimed to describe the frequency, characteristics, and outcomes of patients with…
-
Artikel Jurnal
Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort
Introduction: The National Registry of Rare Kidney Diseases (RaDaR) collects data from people living with rare kidney diseases across the UK, and is the world’s largest, rare kidney disease registry. We present the clinical demographics and renal function of 25,880 prevalent patients and sought…